Pfizer granted patent for solid forms of pyrazolo[3,4-d]pyrimidine compounds.
Pfizer Inc. was granted US patent 12790343 on November 10, 2026, for solid forms of pyrazolo[3,4-d]pyrimidine compounds. The patent is available at https://patentcenter.uspto.gov/applications/18655795.